Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue
Samuel Golpanian, Ariel Wolf, Konstantinos E. Hatzistergos, et al.
Physiological Reviews (2016) Vol. 96, Iss. 3, pp. 1127-1168
Open Access | Times Cited: 294

Showing 1-25 of 294 citing articles:

Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization
Jinxuan Zhao, Xueling Li, Jiaxin Hu, et al.
Cardiovascular Research (2019) Vol. 115, Iss. 7, pp. 1205-1216
Open Access | Times Cited: 603
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy
Joshua M. Hare, Darcy L. DiFede, Angela C. Rieger, et al.
Journal of the American College of Cardiology (2016) Vol. 69, Iss. 5, pp. 526-537
Open Access | Times Cited: 316
Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges
Luiza Bagno, Konstantinos E. Hatzistergos, Wayne Balkan, et al.
Molecular Therapy (2018) Vol. 26, Iss. 7, pp. 1610-1623
Open Access | Times Cited: 285
Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats
Jiangwei Chen, Yingfei Zhan, Yabin Wang, et al.
Acta Biomaterialia (2018) Vol. 80, pp. 154-168
Closed Access | Times Cited: 197
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)
Victoria Florea, Angela C. Rieger, Darcy L. DiFede, et al.
Circulation Research (2017) Vol. 121, Iss. 11, pp. 1279-1290
Open Access | Times Cited: 177
Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease
Abbas Shapouri Moghaddam, Jalil Tavakol Afshari, Seyed‐Alireza Esmaeili, et al.
Atherosclerosis (2019) Vol. 285, pp. 1-9
Closed Access | Times Cited: 177
Donor MSCs release apoptotic bodies to improve myocardial infarction via autophagy regulation in recipient cells
Huan Liu, Siying Liu, Xinyu Qiu, et al.
Autophagy (2020) Vol. 16, Iss. 12, pp. 2140-2155
Open Access | Times Cited: 144
Cyclodextrin-based host–guest supramolecular hydrogels for local drug delivery
Guihua Fang, Xuewen Yang, Sumeng Chen, et al.
Coordination Chemistry Reviews (2021) Vol. 454, pp. 214352-214352
Closed Access | Times Cited: 104
Nicorandil-Pretreated Mesenchymal Stem Cell-Derived Exosomes Facilitate Cardiac Repair After Myocardial Infarction via Promoting Macrophage M2 Polarization by Targeting miR-125a-5p/TRAF6/IRF5 Signaling Pathway
Zhaoting Gong, Yuyan Xiong, Yu Ning, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2005-2024
Open Access | Times Cited: 21
Exosomes From Adipose-derived Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Wnt/β-Catenin Signaling Pathway
Xiaojun Cui, Zhangyou He, Zihao Liang, et al.
Journal of Cardiovascular Pharmacology (2017) Vol. 70, Iss. 4, pp. 225-231
Open Access | Times Cited: 168
Clinical Studies of Cell Therapy in Cardiovascular Medicine
Monisha N. Banerjee, Roberto Bolli, Joshua M. Hare
Circulation Research (2018) Vol. 123, Iss. 2, pp. 266-287
Open Access | Times Cited: 152
Can We Engineer a Human Cardiac Patch for Therapy?
Jianyi Zhang, Wuqiang Zhu, Milica Radisic, et al.
Circulation Research (2018) Vol. 123, Iss. 2, pp. 244-265
Open Access | Times Cited: 136
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Bryon A. Tompkins, Darcy L. DiFede, Aisha Khan, et al.
The Journals of Gerontology Series A (2017) Vol. 72, Iss. 11, pp. 1513-1522
Open Access | Times Cited: 133
CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
Wuqiang Zhu, Meng Zhao, Saidulu Mattapally, et al.
Circulation Research (2017) Vol. 122, Iss. 1, pp. 88-96
Open Access | Times Cited: 131
Preclinical Studies of Stem Cell Therapy for Heart Disease
Bryon A. Tompkins, Wayne Balkan, Johannes Winkler, et al.
Circulation Research (2018) Vol. 122, Iss. 7, pp. 1006-1020
Open Access | Times Cited: 130
Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
Hua Qin, Andong Zhao
Protein & Cell (2020) Vol. 11, Iss. 10, pp. 707-722
Open Access | Times Cited: 122
C1q/Tumor Necrosis Factor–Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways
Wenjun Yan, Yongzhen Guo, Ling Tao, et al.
Circulation (2017) Vol. 136, Iss. 22, pp. 2162-2177
Open Access | Times Cited: 107
Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis
Chider Chen, Dandan Wang, Alireza Moshaverinia, et al.
Cell Research (2017) Vol. 27, Iss. 4, pp. 559-577
Open Access | Times Cited: 106
A mechanistic roadmap for the clinical application of cardiac cell therapies
Eduardo Marbán
Nature Biomedical Engineering (2018) Vol. 2, Iss. 6, pp. 353-361
Open Access | Times Cited: 86
Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p
Jingying Hou, Lingyun Wang, Quanhua Wu, et al.
Stem Cell Research & Therapy (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 84
Mesenchymal Stromal Cells and Exosomes: Progress and Challenges
Matthew H. Forsberg, John A. Kink, Peiman Hematti, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 82
N-Cadherin Overexpression Mobilizes the Protective Effects of Mesenchymal Stromal Cells Against Ischemic Heart Injury Through a β-Catenin–Dependent Manner
Wenjun Yan, Chen Lin, Yongzhen Guo, et al.
Circulation Research (2020) Vol. 126, Iss. 7, pp. 857-874
Open Access | Times Cited: 80
IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway
Mingzhuo Lin, Xinyue Liu, Haoxiao Zheng, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 76
Cell therapy in patients with heart failure: a comprehensive review and emerging concepts
Roberto Bolli, Mitesh Solankhi, Xian‐Liang Tang, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 4, pp. 951-976
Open Access | Times Cited: 76
Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy
Daniel Harding, Ming H. A. Chong, Nishant Lahoti, et al.
Journal of Internal Medicine (2022) Vol. 293, Iss. 1, pp. 23-47
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top